TrialCancer immunology, immunotherapy : CII2008

Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer.

Helga Bernhard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.